Christian Merrill, MD
Sports Medicine · Birmingham, ALNPI 1962899849
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (56.3%), education and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Arthrex at 50.4% of the total. Reporting peaked in 2020 at $29,270 and has fallen 98.6% since, to $423 in 2025.
Across 36 payments — averaging $1109.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$20K
- Smith+Nephew$16K
- DJO, LLC$3K
- Stryker$998
- Medtronic$348
- Zimmer Biomet$177
- plus $233 from 3 others
What the payments were for
- Grants$22,50056%
- Food & beverage$2,1705%
- Education$15,27938%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 2 | $20,125 |
| Smith+Nephew | 5 | $15,568 |
| DJO, LLC | 4 | $2,500 |
| Stryker | 12 | $998 |
| Medtronic | 5 | $348 |
| Zimmer Biomet | 2 | $177 |
| Arteriocyte Medical Systems, Inc. | 1 | $122 |
| Vericel Corporation | 4 | $100 |
| Bioventus LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$289
- GAMMA$169
- MAKO$162
- AccuFill$144
- VISIONAIRE$139
- REGENETEN Shoulder$129
- TRIATHLON$124
- Magellan$122
How this compares
$39,949 in reported general payments places this provider in the 85th percentile of 108 sports medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naproxen | 66 | $528 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 64 | $389 |
| Tranexamic Acid | 28 | $350 |
| Methylprednisolone | 49 | $346 |
| Methocarbamol | 33 | $301 |
| Doxycycline Monohydrate | 23 | $297 |
| Meloxicam | 47 | $144 |
| Cefadroxil | 22 | $143 |
| Tramadol Hcl | 12 | $61 |
| Amoxicillin | 20 | $17 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Birmingham
- Edward CainBirmingham$12.7M
- Mark RogersBirmingham$94K
- Amit MomayaBirmingham$77K
- Christoper GarrettBirmingham$58K
- Reaves CrabtreeBirmingham$47K
- David AdkisonBirmingham$46K
- Amir ShahienBirmingham$45K
- Christopher CarterBirmingham$42K
- Thomas EvelyBirmingham$34K
- Aaron JoinerBirmingham$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.